February 1, 2018 – NRG Oncology Appoints Kati Stoermer for New Executive Director Role

02/01/2018

NRG Oncology, one of the five funded network groups within the National Cancer Institute (NCI)’s National Clinical Trials Network (NCTN), has appointed Kati Stoermer as the organization’s Executive Director. In this new role, Stoermer will be providing oversight and management of the NRG Oncology operational activities coordinated by staff located in Philadelphia and Pittsburgh. She will also be coordinating with the organization’s Statistical and Data Management Center and the group’s Biospecimen Bank. 
Read more

Back

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.